MiNK Therapeutics, Inc.

INKT Stock Healthcare Biotechnology
$10.95
-0.14 (-1.26%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+2.4%
3 Months
-8.4%
YTD
-1.8%
1 Year
-23.1%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
75.0%
Largest decline max drawdown, since Aug 2025
-47.5%
Risk-adjusted return Sharpe ratio, 1-year
0.01

Own INKT?

See how INKT contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.